Title |
LRRK2 at the interface of autophagosomes, endosomes and lysosomes
|
---|---|
Published in |
Molecular Neurodegeneration, December 2016
|
DOI | 10.1186/s13024-016-0140-1 |
Pubmed ID | |
Authors |
Dorien A. Roosen, Mark R. Cookson |
Abstract |
Over the past 20 years, substantial progress has been made in identifying the underlying genetics of Parkinson's disease (PD). Of the known genes, LRRK2 is a major genetic contributor to PD. However, the exact function of LRRK2 remains to be elucidated. In this review, we discuss how familial forms of PD have led us to hypothesize that alterations in endomembrane trafficking play a role in the pathobiology of PD. We will discuss the major observations that have been made to elucidate the role of LRRK2 in particular, including LRRK2 animal models and high-throughput proteomics approaches. Taken together, these studies strongly support a role of LRRK2 in vesicular dynamics. We also propose that targeting these pathways may not only be beneficial for developing therapeutics for LRRK2-driven PD, but also for other familial and sporadic cases. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 50% |
Unknown | 2 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 2 | 50% |
Members of the public | 1 | 25% |
Science communicators (journalists, bloggers, editors) | 1 | 25% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
India | 1 | <1% |
Unknown | 205 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 42 | 20% |
Researcher | 34 | 17% |
Student > Bachelor | 29 | 14% |
Student > Master | 28 | 14% |
Student > Doctoral Student | 6 | 3% |
Other | 19 | 9% |
Unknown | 48 | 23% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 47 | 23% |
Neuroscience | 39 | 19% |
Agricultural and Biological Sciences | 32 | 16% |
Medicine and Dentistry | 14 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 7 | 3% |
Other | 16 | 8% |
Unknown | 51 | 25% |